Results 101 to 110 of about 21,433,686 (207)

PREVALENCE AND SIGNIFICANCE OF ANTIBODY TO HEPATITIS C VIRUS (HCV) IN PATIENTS WITH CHRONIC HEPATITIS TYPE B AND DELTA

, 1989
Prevalence and significance of antibody to hepatitis C virus (HCV) in patients with chronic hepatitis type B and delta is described. HCV worsen clinical course of paitents with chronic hepatitis type
Pontisso P., PONTISSO, PATRIZIA, Tagger A, FATTOVICH, Giovanna, Ferroni P, Realdi G, Ferroni P., Alberti A., Tagger A., Brollo L., Fattovich G, Brollo L, Realdi G.   +12 more
core  

Treatment Response to Sofosbuvir and Ribavirin in Chronic Hepatitis C Patients and Comparison of Naive and Treatment Experienced Patients

Journal of Rawalpindi Medical College, 2018
Background: Sofosbuvir is on the world organization’s list of essential medicines, the most effective and safe medicines needed in health system. It plays a special role in treatment of chronic hepatitis C and offers many advantages due to its high ...
Muhammad Ikhlaq, Maryam Jalil, Syed Dawar, Muhammad Ashraf   +3 more
doaj  

Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort

, 2015
BACKGROUND: Hepatitis A and B vaccines are effective in preventing superinfection and sequelae in patients with chronic hepatitis B or C. We describe immunity and vaccination against hepatitis A and B in chronic hepatitis patients from the US Chronic ...
Vijayadeva, Vinutha, Boscarino, Joseph A, Schmidt, Mark A, Gordon, Stuart C, Lu, Mei, Rupp, Loralee B, Investigators, Chronic Hepatitis Cohort Study (CHeCS), Henkle, Emily   +7 more
core   +1 more source

FREQUENCY OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

Journal of University Medical & Dental College, 2015
: BACKGROUND: In developing countries, Diabetes Mellitus and Hepatitis C virus infection are major public health problems. A range of extra-hepatic manifestation such as artharlgia, thyroiditis and Type 2 Diabetes Mellitus are associated with Hepatitis C
Sumera Riaz, Muhammad Siddique Khan Qadri, Khurram Sohail et al.   +2 more
doaj  

Real-world effectiveness of pangenotypic direct-acting antivirals in chronic hepatitis C: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Çirkin Doruk B, Uğuz M.
europepmc   +1 more source

Comorbidities Associated With Chronic Hepatitis C Among Medicaid Beneficiaries, 2016-2020. [PDF]

Am J Prev Med
Estadt AT, Symum H, Thompson WW, Abimbola TO, Van Handel M.   +4 more
europepmc   +1 more source

Differing Epidemiology of Chronic Hepatitis C Infection, Treatment, and Outcomes Among Migrants and Australian-Born Patients. [PDF]

J Viral Hepat
Taye BW, Valery PC, Strasser SI, Weltman M, Thompson AJ, Levy MT, Leggett B, Zekry A, Rong YJ, Sinclair M, George J, Sievert W, MacQuillan G, Tse E, Wade A, Cheng W, Roberts SK, Clark PJ.   +17 more
europepmc   +1 more source

Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection. [PDF]

Clin Pharmacol Ther
Zitzmann C, Ribeiro RM, Marc A, Zhou XJ, Perelson AS.   +4 more
europepmc   +1 more source

Transition From Interferon-Based Therapy to Direct-Acting Antivirals in Albanian Children With Chronic Hepatitis C: A 17-Year Real-World Experience. [PDF]

Adv Virol
Velmishi V, Dervishi E, Hoxha G, Saraci B, Bali D, Xhafa M, Kapllanaj M, Duka E, Shundi L, Cullufi P.   +9 more
europepmc   +1 more source

Paediatric chronic hepatitis C and the global elimination gap: burden and trends from 1990 to 2023 in the Global Burden of Disease Study 2023. [PDF]

EClinicalMedicine
Hong SJ, Zhang X, Malik F, Goh Suk-Hui L, El-Shabrawi MHF, Ciocca M, Indolfi G, Hardikar W, Kelly D, Schwarz KB, Hartmann P.   +10 more
europepmc   +1 more source